Cardiac MRI
| ASD II | Sinus venosus defect | p Value | |
|---|---|---|---|
| LV EDV/BSA, mean±SD (mL/m2) | 80±15 | 83±16 | 0.6 |
| LV EDV dilation | 5% | 14% | 0.3 |
| LV ESV/BSA | 33±10 | 36±11 | 0.4 |
| LV ESV dilation | 24% | 43% | 0.2 |
| LV EF (%) | 59±7 | 57±8 | 0.4 |
| LV EF decreased | 17% | 29% | 0.4 |
| RV EDV/BSA | 92±15 | 96±16 | 0.4 |
| RV EDV dilation | 17% | 29% | 0.4 |
| RV ESV/BSA | 44±10 | 48±11 | 0.2 |
| RV ESV dilation | 27% | 57% | 0.05 |
| RV EF (%) | 52±6 | 50±7 | 0.2 |
| RV EF decreased | 24% | 50% | 0.1 |
RV EF ≤49% and LV EF≤ 54% were considered decreased and RV EDV >107.5 mL/m2, RV ESV >47.2 mL/m2, LV EDV >102.5 mL/m2 and LV ESV >38.7 mL/m2 were considered enlarged.
BSA, body surface area; EDV, end-diastolic volume; EF, ejection fraction; ESV, end-systolic volume; LV, left ventricle; RV, right ventricle.